China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Needed To Make A Generic Version Of Paxlovid
China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Needed To Make A Generic Version Of Paxlovid
中國國家醫藥產品監督管理局 12 月下旬與包括浙江華海製藥和 CSPC 製藥集團在內的幾家中國製藥商會面，討論製作 Paxlovid 通用版所需的準備工作
China's National Medical Products Administration In Late December Met With Several Chinese Drugmakers Including Zhejiang Huahai Pharmaceutical And CSPC Pharmaceutical Group To Discuss Preparations Needed To Make A Generic Version Of Paxlovid
中國國家醫藥產品監督管理局 12 月下旬與包括浙江華海製藥和 CSPC 製藥集團在內的幾家中國製藥商會面，討論製作 Paxlovid 通用版所需的準備工作
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。